Bupivacaine Liposome Injectable Suspension Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type ( 20ml, 10ml ); Application ( Veterinary, Human )

Report Code: TIPRE00022318 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

EXPAREL is a sterile, non-pyrogenic aqueous suspension of multivesicular liposomes comprising bupivacaine that is white or off-white and free of preservatives. The concentration of bupivacaine is 13.3 mg/mL. Bupivacaine is extracted from the multivesicular liposomes over time after EXPAREL is injected into soft tissue.

MARKET SCOPE

The "Global Bupivacaine Liposome Injectable Suspension Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Bupivacaine Liposome Injectable Suspension market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading Bupivacaine Liposome Injectable Suspension market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
  •   Based on type, the global Bupivacaine Liposome Injectable Suspension market is segmented into 20ml, 10ml.
  •   On the basis of end use, the market is segmented into Veterinary, Human.
MARKET DYNAMICS

Drivers-
  •   With increasing cases of obesity all over the globe
  •   Increasing binge eating and consumption of junk foods, neglect towards regular exercise, rising levels of stress
Restraints-
  •   High cost of drug
REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Bupivacaine Liposome Injectable Suspension market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Bupivacaine Liposome Injectable Suspension market in these regions.

IMPACT OF COVID-19 ON BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION MARKET

Several treatment regimens are being tested around the world in an attempt to find a safe solution for Covid-19. One treatment choice is to use hydroxychloroquine, and another is to use antiviral drugs used in HIV disease management. Many of these tactics increased demand for modern antivirals and antimalarial drugs. This has consequences for pharmaceutical companies since an off-label indication for these drug classes must be created. For the time being, the WHO has not prescribed any of these approaches and has made no determination as to which is superior.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Bupivacaine Liposome Injectable Suspension market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Bupivacaine Liposome Injectable Suspension market are anticipated to lucrative growth opportunities in the future with the rising demand for Bupivacaine Liposome Injectable Suspension in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Bupivacaine Liposome Injectable Suspension market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  •   Pacira Pharmaceuticals
  •   Sun Pharmaceutical Industries Ltd.
  •   Johnson and Johnson
  •   Merck and Co.
  •   Cipla, Inc.
  •   Cadila Pharmaceuticals
  •   SRS Pharmaceuticals Pvt. Ltd.
  •   EXPAREL
  •   Pacira
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Bupivacaine Liposome Injectable Suspension Market - By Type
1.3.2 Bupivacaine Liposome Injectable Suspension Market - By Application
1.3.3 Bupivacaine Liposome Injectable Suspension Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION MARKET - GLOBAL MARKET ANALYSIS
6.1. BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION - GLOBAL MARKET OVERVIEW
6.2. BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. 20ML
7.3.1. Overview
7.3.2. 20ml Market Forecast and Analysis
7.4. 10ML
7.4.1. Overview
7.4.2. 10ml Market Forecast and Analysis
8. BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. VETERINARY
8.3.1. Overview
8.3.2. Veterinary Market Forecast and Analysis
8.4. HUMAN
8.4.1. Overview
8.4.2. Human Market Forecast and Analysis
9. BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Bupivacaine Liposome Injectable Suspension Market Overview
9.1.2 North America Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis
9.1.3 North America Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis - By Type
9.1.4 North America Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis - By Application
9.1.5 North America Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis - By Countries
9.1.5.1 United States Bupivacaine Liposome Injectable Suspension Market
9.1.5.1.1 United States Bupivacaine Liposome Injectable Suspension Market by Type
9.1.5.1.2 United States Bupivacaine Liposome Injectable Suspension Market by Application
9.1.5.2 Canada Bupivacaine Liposome Injectable Suspension Market
9.1.5.2.1 Canada Bupivacaine Liposome Injectable Suspension Market by Type
9.1.5.2.2 Canada Bupivacaine Liposome Injectable Suspension Market by Application
9.1.5.3 Mexico Bupivacaine Liposome Injectable Suspension Market
9.1.5.3.1 Mexico Bupivacaine Liposome Injectable Suspension Market by Type
9.1.5.3.2 Mexico Bupivacaine Liposome Injectable Suspension Market by Application
9.2. EUROPE
9.2.1 Europe Bupivacaine Liposome Injectable Suspension Market Overview
9.2.2 Europe Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis
9.2.3 Europe Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis - By Type
9.2.4 Europe Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis - By Application
9.2.5 Europe Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Bupivacaine Liposome Injectable Suspension Market
9.2.5.1.1 Germany Bupivacaine Liposome Injectable Suspension Market by Type
9.2.5.1.2 Germany Bupivacaine Liposome Injectable Suspension Market by Application
9.2.5.2 France Bupivacaine Liposome Injectable Suspension Market
9.2.5.2.1 France Bupivacaine Liposome Injectable Suspension Market by Type
9.2.5.2.2 France Bupivacaine Liposome Injectable Suspension Market by Application
9.2.5.3 Italy Bupivacaine Liposome Injectable Suspension Market
9.2.5.3.1 Italy Bupivacaine Liposome Injectable Suspension Market by Type
9.2.5.3.2 Italy Bupivacaine Liposome Injectable Suspension Market by Application
9.2.5.4 Spain Bupivacaine Liposome Injectable Suspension Market
9.2.5.4.1 Spain Bupivacaine Liposome Injectable Suspension Market by Type
9.2.5.4.2 Spain Bupivacaine Liposome Injectable Suspension Market by Application
9.2.5.5 United Kingdom Bupivacaine Liposome Injectable Suspension Market
9.2.5.5.1 United Kingdom Bupivacaine Liposome Injectable Suspension Market by Type
9.2.5.5.2 United Kingdom Bupivacaine Liposome Injectable Suspension Market by Application
9.2.5.6 Rest of Europe Bupivacaine Liposome Injectable Suspension Market
9.2.5.6.1 Rest of Europe Bupivacaine Liposome Injectable Suspension Market by Type
9.2.5.6.2 Rest of Europe Bupivacaine Liposome Injectable Suspension Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Bupivacaine Liposome Injectable Suspension Market Overview
9.3.2 Asia-Pacific Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis
9.3.3 Asia-Pacific Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Bupivacaine Liposome Injectable Suspension Market
9.3.5.1.1 Australia Bupivacaine Liposome Injectable Suspension Market by Type
9.3.5.1.2 Australia Bupivacaine Liposome Injectable Suspension Market by Application
9.3.5.2 China Bupivacaine Liposome Injectable Suspension Market
9.3.5.2.1 China Bupivacaine Liposome Injectable Suspension Market by Type
9.3.5.2.2 China Bupivacaine Liposome Injectable Suspension Market by Application
9.3.5.3 India Bupivacaine Liposome Injectable Suspension Market
9.3.5.3.1 India Bupivacaine Liposome Injectable Suspension Market by Type
9.3.5.3.2 India Bupivacaine Liposome Injectable Suspension Market by Application
9.3.5.4 Japan Bupivacaine Liposome Injectable Suspension Market
9.3.5.4.1 Japan Bupivacaine Liposome Injectable Suspension Market by Type
9.3.5.4.2 Japan Bupivacaine Liposome Injectable Suspension Market by Application
9.3.5.5 South Korea Bupivacaine Liposome Injectable Suspension Market
9.3.5.5.1 South Korea Bupivacaine Liposome Injectable Suspension Market by Type
9.3.5.5.2 South Korea Bupivacaine Liposome Injectable Suspension Market by Application
9.3.5.6 Rest of Asia-Pacific Bupivacaine Liposome Injectable Suspension Market
9.3.5.6.1 Rest of Asia-Pacific Bupivacaine Liposome Injectable Suspension Market by Type
9.3.5.6.2 Rest of Asia-Pacific Bupivacaine Liposome Injectable Suspension Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Bupivacaine Liposome Injectable Suspension Market Overview
9.4.2 Middle East and Africa Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis
9.4.3 Middle East and Africa Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Bupivacaine Liposome Injectable Suspension Market
9.4.5.1.1 South Africa Bupivacaine Liposome Injectable Suspension Market by Type
9.4.5.1.2 South Africa Bupivacaine Liposome Injectable Suspension Market by Application
9.4.5.2 Saudi Arabia Bupivacaine Liposome Injectable Suspension Market
9.4.5.2.1 Saudi Arabia Bupivacaine Liposome Injectable Suspension Market by Type
9.4.5.2.2 Saudi Arabia Bupivacaine Liposome Injectable Suspension Market by Application
9.4.5.3 U.A.E Bupivacaine Liposome Injectable Suspension Market
9.4.5.3.1 U.A.E Bupivacaine Liposome Injectable Suspension Market by Type
9.4.5.3.2 U.A.E Bupivacaine Liposome Injectable Suspension Market by Application
9.4.5.4 Rest of Middle East and Africa Bupivacaine Liposome Injectable Suspension Market
9.4.5.4.1 Rest of Middle East and Africa Bupivacaine Liposome Injectable Suspension Market by Type
9.4.5.4.2 Rest of Middle East and Africa Bupivacaine Liposome Injectable Suspension Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Bupivacaine Liposome Injectable Suspension Market Overview
9.5.2 South and Central America Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis
9.5.3 South and Central America Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis - By Type
9.5.4 South and Central America Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis - By Application
9.5.5 South and Central America Bupivacaine Liposome Injectable Suspension Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Bupivacaine Liposome Injectable Suspension Market
9.5.5.1.1 Brazil Bupivacaine Liposome Injectable Suspension Market by Type
9.5.5.1.2 Brazil Bupivacaine Liposome Injectable Suspension Market by Application
9.5.5.2 Argentina Bupivacaine Liposome Injectable Suspension Market
9.5.5.2.1 Argentina Bupivacaine Liposome Injectable Suspension Market by Type
9.5.5.2.2 Argentina Bupivacaine Liposome Injectable Suspension Market by Application
9.5.5.3 Rest of South and Central America Bupivacaine Liposome Injectable Suspension Market
9.5.5.3.1 Rest of South and Central America Bupivacaine Liposome Injectable Suspension Market by Type
9.5.5.3.2 Rest of South and Central America Bupivacaine Liposome Injectable Suspension Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOINT VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION MARKET, KEY COMPANY PROFILES
12.1. PACIRA PHARMACEUTICALS
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SUN PHARMACEUTICAL INDUSTRIES LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. JOHNSON AND JOHNSON
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MERCK AND CO.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CIPLA, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CADILA PHARMACEUTICALS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SRS PHARMACEUTICALS PVT. LTD.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. EXPAREL
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS


* Above given report scope is tentative, and may change during the study process as per the research requirement.
* List of companies provided under ‘Company Profile’ chapter is tentative and may change during the course of the study. This list is customizable as per the client requirements.
* Financial information would be provided only for the public companies.
?
LIST OF TABLES

TABLE 1. Table 1
TABLE 2. Table 2
TABLE 3. Table 3
?
LIST OF FIGURES

FIGURE 1. Figure 1
The List of Companies

1. Pacira Pharmaceuticals
2. Sun Pharmaceutical Industries Ltd.
3. Johnson and Johnson
4. Merck and Co.
5. Cipla, Inc.
6. Cadila Pharmaceuticals
7. SRS Pharmaceuticals Pvt. Ltd.
8. EXPAREL
9. Pacira
TIPRE00022318
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking